Viatris(US:VTRS)2025-08-07 12:30Financial Performance - Q2 2025 total revenues were $3582 million, a decrease of 6% compared to Q2 2024[39] - Adjusted EBITDA for Q2 2025 was $1079 million, an 11% decrease compared to Q2 2024[39] - Adjusted EPS for Q2 2025 was $062, a 10% decrease compared to Q2 2024[39] - Free cash flow for Q2 2025 was $167 million, or $241 million excluding transaction-related costs[39, 40] Impact of Indore Facility - The estimated negative impact on 2025 total revenues due to the Indore facility is approximately $500 million, with an estimated $385 million impact on adjusted EBITDA[2, 58] - The Q2 2025 Indore impact to earnings from operations and adjusted EBITDA is estimated to be approximately $110 million[58, 60] - Estimated 2025 net sales impact by region due to the Indore facility: North America ~$300 million, Europe ~$75 million, and Emerging Markets ~$125 million[2, 58] Financial Guidance - The company reaffirms its 2025 financial guidance, with total revenues expected to be between $135 billion and $140 billion[2, 63] - Adjusted EBITDA is expected to be between $389 billion and $419 billion, and adjusted EPS is expected to be between $216 and $230[2, 63] - The company expects to complete share repurchases totaling between $500 million and $650 million in 2025[2] Business Segment Performance - Developed Markets net sales were $2119 million, a decrease of 9% compared to Q2 2024[46] - Emerging Markets net sales were $555 million, a decrease of 4% compared to Q2 2024[49] - Greater China net sales were $589 million, an increase of 9% compared to Q2 2024[55]